Improvement of psychiatrists’ clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the ‘Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)’ project: A nationwide dissemination, education, and evaluation study

Yoshikazu Takaesu, Koichiro Watanabe, Shusuke Numata, Masaaki Iwata, Noriko Kudo, Satoru Oishi, Takeya Takizawa, Kiyotaka Nemoto, Yuka Yasuda, Hiromi Tagata, Takashi Tsuboi, Naohisa Tsujino, Naoki Hashimoto, Yuki Matsui, Hikaru Hori, Hidenaga Yamamori, Nobuhiro Sugiyama, Taro Suwa, Taishiro Kishimoto, Akitoyo HishimotoMasahide Usami, Ryuji Furihata, Kunihiro Iwamoto, Hiroshige Fujishiro, Toshinori Nakamura, Kentaro Mizuno, Takahiko Inagaki, Eiichi Katsumoto, Hiroaki Tomita, Kazutaka Ohi, Hiroyuki Muraoka, Kiyokazu Atake, Hitoshi Iida, Tatsuya Nagasawa, Junichi Fujita, Satoshi Yamamura, Toshiaki Onitsuka, Atsunobu Murata, Yoichiro Takayanagi, Hokuto Noda, Yukiko Matsumura, Kenji Takezawa, Jun ichi Iga, Kayo Ichihashi, Kazuyoshi Ogasawara, Hisashi Yamada, Ken Inada, Ryota Hashimoto

Research output: Contribution to journalArticle

Abstract

Aim: Although treatment guidelines for pharmacological therapy for schizophrenia and major depressive disorder have been issued by the Japanese Societies of Neuropsychopharmacology and Mood Disorders, these guidelines have not been well applied by psychiatrists throughout the nation. To address this issue, we developed the ‘Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)’ integrated education programs for psychiatrists to disseminate the clinical guidelines. Additionally, we conducted a systematic efficacy evaluation of the programs. Methods: Four hundred thirteen out of 461 psychiatrists attended two 1-day educational programs based on the treatment guidelines for schizophrenia and major depressive disorder from October 2016 to March 2018. We measured the participants’ clinical knowledge of the treatment guidelines using self-completed questionnaires administered before and after the program to assess the effectiveness of the programs for improving knowledge. We also examined the relation between the participants’ demographics and their clinical knowledge scores. Results: The clinical knowledge scores for both guidelines were significantly improved after the program. There was no correlation between clinical knowledge and participant demographics for the program on schizophrenia; however, a weak positive correlation was found between clinical knowledge and the years of professional experience for the program on major depressive disorder. Conclusion: Our results provide evidence that educational programs on the clinical practices recommended in guidelines for schizophrenia and major depressive disorder might effectively improve participants’ clinical knowledge of the guidelines. These data are encouraging to facilitate the standardization of clinical practices for psychiatric disorders.

Original languageEnglish
Pages (from-to)642-648
Number of pages7
JournalPsychiatry and Clinical Neurosciences
Volume73
Issue number10
DOIs
Publication statusPublished - 2019 Oct 1

Fingerprint

Major Depressive Disorder
Psychiatry
Schizophrenia
Guidelines
Education
Program Evaluation
Demography
Mood Disorders
Pharmacology

Keywords

  • educational program
  • EGUIDE project
  • major depressive disorder
  • schizophrenia
  • treatment guideline

ASJC Scopus subject areas

  • Neuroscience(all)
  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health

Cite this

Improvement of psychiatrists’ clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the ‘Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)’ project : A nationwide dissemination, education, and evaluation study. / Takaesu, Yoshikazu; Watanabe, Koichiro; Numata, Shusuke; Iwata, Masaaki; Kudo, Noriko; Oishi, Satoru; Takizawa, Takeya; Nemoto, Kiyotaka; Yasuda, Yuka; Tagata, Hiromi; Tsuboi, Takashi; Tsujino, Naohisa; Hashimoto, Naoki; Matsui, Yuki; Hori, Hikaru; Yamamori, Hidenaga; Sugiyama, Nobuhiro; Suwa, Taro; Kishimoto, Taishiro; Hishimoto, Akitoyo; Usami, Masahide; Furihata, Ryuji; Iwamoto, Kunihiro; Fujishiro, Hiroshige; Nakamura, Toshinori; Mizuno, Kentaro; Inagaki, Takahiko; Katsumoto, Eiichi; Tomita, Hiroaki; Ohi, Kazutaka; Muraoka, Hiroyuki; Atake, Kiyokazu; Iida, Hitoshi; Nagasawa, Tatsuya; Fujita, Junichi; Yamamura, Satoshi; Onitsuka, Toshiaki; Murata, Atsunobu; Takayanagi, Yoichiro; Noda, Hokuto; Matsumura, Yukiko; Takezawa, Kenji; Iga, Jun ichi; Ichihashi, Kayo; Ogasawara, Kazuyoshi; Yamada, Hisashi; Inada, Ken; Hashimoto, Ryota.

In: Psychiatry and Clinical Neurosciences, Vol. 73, No. 10, 01.10.2019, p. 642-648.

Research output: Contribution to journalArticle

Takaesu, Y, Watanabe, K, Numata, S, Iwata, M, Kudo, N, Oishi, S, Takizawa, T, Nemoto, K, Yasuda, Y, Tagata, H, Tsuboi, T, Tsujino, N, Hashimoto, N, Matsui, Y, Hori, H, Yamamori, H, Sugiyama, N, Suwa, T, Kishimoto, T, Hishimoto, A, Usami, M, Furihata, R, Iwamoto, K, Fujishiro, H, Nakamura, T, Mizuno, K, Inagaki, T, Katsumoto, E, Tomita, H, Ohi, K, Muraoka, H, Atake, K, Iida, H, Nagasawa, T, Fujita, J, Yamamura, S, Onitsuka, T, Murata, A, Takayanagi, Y, Noda, H, Matsumura, Y, Takezawa, K, Iga, JI, Ichihashi, K, Ogasawara, K, Yamada, H, Inada, K & Hashimoto, R 2019, 'Improvement of psychiatrists’ clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the ‘Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)’ project: A nationwide dissemination, education, and evaluation study', Psychiatry and Clinical Neurosciences, vol. 73, no. 10, pp. 642-648. https://doi.org/10.1111/pcn.12911
Takaesu, Yoshikazu ; Watanabe, Koichiro ; Numata, Shusuke ; Iwata, Masaaki ; Kudo, Noriko ; Oishi, Satoru ; Takizawa, Takeya ; Nemoto, Kiyotaka ; Yasuda, Yuka ; Tagata, Hiromi ; Tsuboi, Takashi ; Tsujino, Naohisa ; Hashimoto, Naoki ; Matsui, Yuki ; Hori, Hikaru ; Yamamori, Hidenaga ; Sugiyama, Nobuhiro ; Suwa, Taro ; Kishimoto, Taishiro ; Hishimoto, Akitoyo ; Usami, Masahide ; Furihata, Ryuji ; Iwamoto, Kunihiro ; Fujishiro, Hiroshige ; Nakamura, Toshinori ; Mizuno, Kentaro ; Inagaki, Takahiko ; Katsumoto, Eiichi ; Tomita, Hiroaki ; Ohi, Kazutaka ; Muraoka, Hiroyuki ; Atake, Kiyokazu ; Iida, Hitoshi ; Nagasawa, Tatsuya ; Fujita, Junichi ; Yamamura, Satoshi ; Onitsuka, Toshiaki ; Murata, Atsunobu ; Takayanagi, Yoichiro ; Noda, Hokuto ; Matsumura, Yukiko ; Takezawa, Kenji ; Iga, Jun ichi ; Ichihashi, Kayo ; Ogasawara, Kazuyoshi ; Yamada, Hisashi ; Inada, Ken ; Hashimoto, Ryota. / Improvement of psychiatrists’ clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the ‘Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)’ project : A nationwide dissemination, education, and evaluation study. In: Psychiatry and Clinical Neurosciences. 2019 ; Vol. 73, No. 10. pp. 642-648.
@article{bd399c870f8248c4a0cf8707c7d9aa54,
title = "Improvement of psychiatrists’ clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the ‘Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)’ project: A nationwide dissemination, education, and evaluation study",
abstract = "Aim: Although treatment guidelines for pharmacological therapy for schizophrenia and major depressive disorder have been issued by the Japanese Societies of Neuropsychopharmacology and Mood Disorders, these guidelines have not been well applied by psychiatrists throughout the nation. To address this issue, we developed the ‘Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)’ integrated education programs for psychiatrists to disseminate the clinical guidelines. Additionally, we conducted a systematic efficacy evaluation of the programs. Methods: Four hundred thirteen out of 461 psychiatrists attended two 1-day educational programs based on the treatment guidelines for schizophrenia and major depressive disorder from October 2016 to March 2018. We measured the participants’ clinical knowledge of the treatment guidelines using self-completed questionnaires administered before and after the program to assess the effectiveness of the programs for improving knowledge. We also examined the relation between the participants’ demographics and their clinical knowledge scores. Results: The clinical knowledge scores for both guidelines were significantly improved after the program. There was no correlation between clinical knowledge and participant demographics for the program on schizophrenia; however, a weak positive correlation was found between clinical knowledge and the years of professional experience for the program on major depressive disorder. Conclusion: Our results provide evidence that educational programs on the clinical practices recommended in guidelines for schizophrenia and major depressive disorder might effectively improve participants’ clinical knowledge of the guidelines. These data are encouraging to facilitate the standardization of clinical practices for psychiatric disorders.",
keywords = "educational program, EGUIDE project, major depressive disorder, schizophrenia, treatment guideline",
author = "Yoshikazu Takaesu and Koichiro Watanabe and Shusuke Numata and Masaaki Iwata and Noriko Kudo and Satoru Oishi and Takeya Takizawa and Kiyotaka Nemoto and Yuka Yasuda and Hiromi Tagata and Takashi Tsuboi and Naohisa Tsujino and Naoki Hashimoto and Yuki Matsui and Hikaru Hori and Hidenaga Yamamori and Nobuhiro Sugiyama and Taro Suwa and Taishiro Kishimoto and Akitoyo Hishimoto and Masahide Usami and Ryuji Furihata and Kunihiro Iwamoto and Hiroshige Fujishiro and Toshinori Nakamura and Kentaro Mizuno and Takahiko Inagaki and Eiichi Katsumoto and Hiroaki Tomita and Kazutaka Ohi and Hiroyuki Muraoka and Kiyokazu Atake and Hitoshi Iida and Tatsuya Nagasawa and Junichi Fujita and Satoshi Yamamura and Toshiaki Onitsuka and Atsunobu Murata and Yoichiro Takayanagi and Hokuto Noda and Yukiko Matsumura and Kenji Takezawa and Iga, {Jun ichi} and Kayo Ichihashi and Kazuyoshi Ogasawara and Hisashi Yamada and Ken Inada and Ryota Hashimoto",
year = "2019",
month = "10",
day = "1",
doi = "10.1111/pcn.12911",
language = "English",
volume = "73",
pages = "642--648",
journal = "Psychiatry and Clinical Neurosciences",
issn = "1323-1316",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Improvement of psychiatrists’ clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the ‘Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)’ project

T2 - A nationwide dissemination, education, and evaluation study

AU - Takaesu, Yoshikazu

AU - Watanabe, Koichiro

AU - Numata, Shusuke

AU - Iwata, Masaaki

AU - Kudo, Noriko

AU - Oishi, Satoru

AU - Takizawa, Takeya

AU - Nemoto, Kiyotaka

AU - Yasuda, Yuka

AU - Tagata, Hiromi

AU - Tsuboi, Takashi

AU - Tsujino, Naohisa

AU - Hashimoto, Naoki

AU - Matsui, Yuki

AU - Hori, Hikaru

AU - Yamamori, Hidenaga

AU - Sugiyama, Nobuhiro

AU - Suwa, Taro

AU - Kishimoto, Taishiro

AU - Hishimoto, Akitoyo

AU - Usami, Masahide

AU - Furihata, Ryuji

AU - Iwamoto, Kunihiro

AU - Fujishiro, Hiroshige

AU - Nakamura, Toshinori

AU - Mizuno, Kentaro

AU - Inagaki, Takahiko

AU - Katsumoto, Eiichi

AU - Tomita, Hiroaki

AU - Ohi, Kazutaka

AU - Muraoka, Hiroyuki

AU - Atake, Kiyokazu

AU - Iida, Hitoshi

AU - Nagasawa, Tatsuya

AU - Fujita, Junichi

AU - Yamamura, Satoshi

AU - Onitsuka, Toshiaki

AU - Murata, Atsunobu

AU - Takayanagi, Yoichiro

AU - Noda, Hokuto

AU - Matsumura, Yukiko

AU - Takezawa, Kenji

AU - Iga, Jun ichi

AU - Ichihashi, Kayo

AU - Ogasawara, Kazuyoshi

AU - Yamada, Hisashi

AU - Inada, Ken

AU - Hashimoto, Ryota

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Aim: Although treatment guidelines for pharmacological therapy for schizophrenia and major depressive disorder have been issued by the Japanese Societies of Neuropsychopharmacology and Mood Disorders, these guidelines have not been well applied by psychiatrists throughout the nation. To address this issue, we developed the ‘Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)’ integrated education programs for psychiatrists to disseminate the clinical guidelines. Additionally, we conducted a systematic efficacy evaluation of the programs. Methods: Four hundred thirteen out of 461 psychiatrists attended two 1-day educational programs based on the treatment guidelines for schizophrenia and major depressive disorder from October 2016 to March 2018. We measured the participants’ clinical knowledge of the treatment guidelines using self-completed questionnaires administered before and after the program to assess the effectiveness of the programs for improving knowledge. We also examined the relation between the participants’ demographics and their clinical knowledge scores. Results: The clinical knowledge scores for both guidelines were significantly improved after the program. There was no correlation between clinical knowledge and participant demographics for the program on schizophrenia; however, a weak positive correlation was found between clinical knowledge and the years of professional experience for the program on major depressive disorder. Conclusion: Our results provide evidence that educational programs on the clinical practices recommended in guidelines for schizophrenia and major depressive disorder might effectively improve participants’ clinical knowledge of the guidelines. These data are encouraging to facilitate the standardization of clinical practices for psychiatric disorders.

AB - Aim: Although treatment guidelines for pharmacological therapy for schizophrenia and major depressive disorder have been issued by the Japanese Societies of Neuropsychopharmacology and Mood Disorders, these guidelines have not been well applied by psychiatrists throughout the nation. To address this issue, we developed the ‘Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)’ integrated education programs for psychiatrists to disseminate the clinical guidelines. Additionally, we conducted a systematic efficacy evaluation of the programs. Methods: Four hundred thirteen out of 461 psychiatrists attended two 1-day educational programs based on the treatment guidelines for schizophrenia and major depressive disorder from October 2016 to March 2018. We measured the participants’ clinical knowledge of the treatment guidelines using self-completed questionnaires administered before and after the program to assess the effectiveness of the programs for improving knowledge. We also examined the relation between the participants’ demographics and their clinical knowledge scores. Results: The clinical knowledge scores for both guidelines were significantly improved after the program. There was no correlation between clinical knowledge and participant demographics for the program on schizophrenia; however, a weak positive correlation was found between clinical knowledge and the years of professional experience for the program on major depressive disorder. Conclusion: Our results provide evidence that educational programs on the clinical practices recommended in guidelines for schizophrenia and major depressive disorder might effectively improve participants’ clinical knowledge of the guidelines. These data are encouraging to facilitate the standardization of clinical practices for psychiatric disorders.

KW - educational program

KW - EGUIDE project

KW - major depressive disorder

KW - schizophrenia

KW - treatment guideline

UR - http://www.scopus.com/inward/record.url?scp=85070933489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070933489&partnerID=8YFLogxK

U2 - 10.1111/pcn.12911

DO - 10.1111/pcn.12911

M3 - Article

C2 - 31437336

AN - SCOPUS:85070933489

VL - 73

SP - 642

EP - 648

JO - Psychiatry and Clinical Neurosciences

JF - Psychiatry and Clinical Neurosciences

SN - 1323-1316

IS - 10

ER -